Highly significant reduction of HIV-1 pVL was obtained in the lowest vaccine dose.
← all excerpts
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials.
1
—
—
Highly significant reduction of HIV-1 pVL was obtained in the lowest vaccine dose.